These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28317227)

  • 1. Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital.
    Ow D; Papa N; Perera M; Liodakis P; Sengupta S; Clarke S; Bolton DM; Lawrentschuk N
    ANZ J Surg; 2018 Jan; 88(1-2):95-99. PubMed ID: 28317227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012.
    Thangasamy IA; Chalasani V; Bachmann A; Woo HH
    Eur Urol; 2012 Aug; 62(2):315-23. PubMed ID: 22575913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Photoselective Vaporization of the Prostate with 120 W 532 nm Laser in Patients with Benign Prostatic Hyperplasia on Anticoagulation or Antiplatelet Therapy: Observations on Long-Term Outcomes.
    Piotrowicz G; Syryło T; Jedynak R; Zieliński H
    Photomed Laser Surg; 2018 May; 36(5):273-283. PubMed ID: 29227749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP.
    Olcese SP; Derosa R; Kern SQ; Lustik MB; Sterbis JR; McMann LP
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):227-32. PubMed ID: 24732080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up.
    Tasci AI; Tugcu V; Sahin S; Zorluoglu F
    J Endourol; 2008 Feb; 22(2):347-53. PubMed ID: 18257671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 160-Watt lithium triboride laser vaporization versus transurethral resection of prostate: a prospective nonrandomized two-center trial.
    Chen J; Wang M; Wang S; Sun P; Zhao Y; Zhang L; Jin X
    Urology; 2012 Mar; 79(3):650-4. PubMed ID: 22386419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up.
    Cimino S; Voce S; Palmieri F; Favilla V; Castelli T; Privitera S; Giardina R; Reale G; Russo GI; Morgia G
    Int J Impot Res; 2017 Nov; 29(6):240-243. PubMed ID: 28814812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of transurethral surgery for benign prostatic hyperplasia: a nationwide survey in Japan.
    Okamura K; Nojiri Y; Seki N; Arai Y; Matsuda T; Hattori R; Hasegawa T; Naito S
    Int J Urol; 2011 Apr; 18(4):304-10. PubMed ID: 21276084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative and economic analysis of surgical treatments for benign prostatic hyperplasia: A study of the French committee on LUT.
    Mathieu R; Lebdai S; Cornu JN; Benchikh A; Azzouzi AR; Delongchamps NB; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Misrai V; de La Taille A; Robert G; Descazeaud A
    Prog Urol; 2017 May; 27(6):362-368. PubMed ID: 28495071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Perioperative Outcomes Across Major Benign Prostatic Hyperplasia Procedures from the ACS-NSQIP 2011-2015.
    Anderson BB; Heiman J; Large T; Lingeman J; Krambeck A
    J Endourol; 2019 Jan; 33(1):62-68. PubMed ID: 30039715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term risks of photoselective laser vaporization of the prostate: a population-based comparison with transurethral resection of the prostate.
    Salmivalli A; Ettala O; Nurminen P; Kinnala P; Boström PJ; Kytö V
    Ann Med; 2023 Dec; 55(1):1287-1294. PubMed ID: 36974584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally Invasive Treatment for Benign Prostatic Hyperplasia: Economic Evaluation from a Standardized Hospital Case Costing System.
    Brown AD; Stella SF; Simons ME
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):520-527. PubMed ID: 30506168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial.
    Lukacs B; Loeffler J; Bruyère F; Blanchet P; Gelet A; Coloby P; De la Taille A; Lemaire P; Baron JC; Cornu JN; Aout M; Rousseau H; Vicaut E;
    Eur Urol; 2012 Jun; 61(6):1165-73. PubMed ID: 22341632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.
    Horasanli K; Silay MS; Altay B; Tanriverdi O; Sarica K; Miroglu C
    Urology; 2008 Feb; 71(2):247-51. PubMed ID: 18308094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.